<DOC>
	<DOCNO>NCT01006122</DOCNO>
	<brief_summary>Histaminergic agent know involved sleep/wake cycle . This compound histaminergic agent therefore may improve alertness awakeness patient excessive daytime sleepiness ( EDS ) associate narcolepsy . Significant improvement EDS treat compound compare placebo patient narcolepsy hypothesize .</brief_summary>
	<brief_title>A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy</brief_title>
	<detailed_description />
	<mesh_term>Narcolepsy</mesh_term>
	<criteria>ISDC diagnosis narcolepsy Excessive Daytime Sleepiness association diagnosis narcolepsy An MWT ( Maintenance Wakefulness Test ) average sleep latency 15 minute Baseline No diagnose sleep disorder ( e.g. , sleep apnea ) Major medical disorder Major psychiatric disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Randomized</keyword>
	<keyword>double-blind</keyword>
	<keyword>placebo-controlled</keyword>
	<keyword>crossover study PF-03654746 Excessive Daytime Sleepiness associate Narcolepsy</keyword>
</DOC>